Innophos Holdings (Nasdaq: IPHS ) reported earnings on Feb. 21. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Innophos Holdings missed estimates on revenues and beat expectations on earnings per share.
Compared with the prior-year quarter, revenue expanded and GAAP earnings per share improved.
Gross margins contracted, operating margins dropped, net margins were steady.
Innophos Holdings reported revenue of $209.2 million. The three analysts polled by S&P Capital IQ foresaw a top line of $214.6 million on the same basis. GAAP reported sales were 8.8% higher than the prior-year quarter's $192.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Non-GAAP EPS came in at $0.88. The four earnings estimates compiled by S&P Capital IQ anticipated $0.87 per share on the same basis. GAAP EPS of $0.93 for Q4 were 8.1% higher than the prior-year quarter's $0.86 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 23.7%, 2,330 basis points worse than the prior-year quarter. Operating margin was 14.6%, 2,310 basis points worse than the prior-year quarter. Net margin was 10.0%, about the same as the prior-year quarter.
Next quarter's average estimate for revenue is $219.6 million. On the bottom line, the average EPS estimate is $0.96.
Next year's average estimate for revenue is $876.6 million. The average EPS estimate is $4.05.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 823 members out of 847 rating the stock outperform, and 24 members rating it underperform. Among 294 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 289 give Innophos Holdings a green thumbs-up, and five give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Innophos Holdings is outperform, with an average price target of $57.33.
Over the decades, small-cap stocks like Innophos Holdings have provided market-beating returns, provided they're value -priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Get instant access to this free report.